Lasa Supergenerics Limited (BOM:540702)
16.71
+0.04 (0.24%)
At close: May 9, 2025
Lasa Supergenerics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2017 - 2019 |
Operating Revenue | 1,261 | 1,043 | 1,296 | 1,371 | 2,024 | 1,673 | Upgrade
|
Other Revenue | 0.75 | 0.75 | 8.62 | - | - | - | Upgrade
|
Revenue | 1,262 | 1,044 | 1,304 | 1,371 | 2,024 | 1,673 | Upgrade
|
Revenue Growth (YoY) | 8.01% | -19.95% | -4.88% | -32.24% | 21.00% | -1.37% | Upgrade
|
Cost of Revenue | 984.92 | 773.72 | 1,075 | 897.68 | 1,163 | 974.32 | Upgrade
|
Gross Profit | 277.09 | 270.38 | 229.09 | 473.59 | 860.47 | 698.25 | Upgrade
|
Selling, General & Admin | 64.88 | 66.43 | 79.64 | 73.77 | 144.82 | 141.83 | Upgrade
|
Other Operating Expenses | 216.73 | 180.79 | 187.62 | 207.24 | 243 | 227.2 | Upgrade
|
Operating Expenses | 392.22 | 353.95 | 401.45 | 426.12 | 546.06 | 542.42 | Upgrade
|
Operating Income | -115.13 | -83.57 | -172.36 | 47.47 | 314.41 | 155.83 | Upgrade
|
Interest Expense | -31.87 | -19.74 | -41.54 | -0.25 | -16.76 | -72.96 | Upgrade
|
Interest & Investment Income | 0.25 | 0.25 | 0.27 | 0.85 | 0.49 | 2.32 | Upgrade
|
Currency Exchange Gain (Loss) | -0.16 | -0.16 | -16.42 | -7.3 | 1.17 | -2.6 | Upgrade
|
Other Non Operating Income (Expenses) | 19.84 | -0.18 | -0.36 | -0.28 | -3.8 | -8.28 | Upgrade
|
EBT Excluding Unusual Items | -127.06 | -103.39 | -230.41 | 40.5 | 295.52 | 74.3 | Upgrade
|
Merger & Restructuring Charges | - | - | - | - | -0.5 | - | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | 6.72 | 0.94 | -0.1 | -2.1 | Upgrade
|
Asset Writedown | -23.22 | -23.22 | - | - | - | -23.72 | Upgrade
|
Other Unusual Items | 17.94 | -64.51 | -198.97 | -102.83 | - | -1.13 | Upgrade
|
Pretax Income | -132.34 | -191.13 | -422.65 | -61.39 | 294.91 | 47.36 | Upgrade
|
Income Tax Expense | 25.32 | 26.18 | -36.44 | -8.08 | 67.14 | 11.08 | Upgrade
|
Net Income | -157.66 | -217.31 | -386.21 | -53.31 | 227.78 | 36.28 | Upgrade
|
Net Income to Common | -157.66 | -217.31 | -386.21 | -53.31 | 227.78 | 36.28 | Upgrade
|
Net Income Growth | - | - | - | - | 527.76% | - | Upgrade
|
Shares Outstanding (Basic) | 51 | 50 | 50 | 50 | 41 | 41 | Upgrade
|
Shares Outstanding (Diluted) | 51 | 50 | 50 | 50 | 41 | 41 | Upgrade
|
Shares Change (YoY) | -10.43% | - | -0.39% | 23.66% | - | 77.89% | Upgrade
|
EPS (Basic) | -3.07 | -4.34 | -7.71 | -1.06 | 5.60 | 0.89 | Upgrade
|
EPS (Diluted) | -3.08 | -4.34 | -7.71 | -1.06 | 5.60 | 0.89 | Upgrade
|
EPS Growth | - | - | - | - | 529.21% | - | Upgrade
|
Free Cash Flow | - | 21.39 | -173 | 92.12 | 347.24 | 129.96 | Upgrade
|
Free Cash Flow Per Share | - | 0.43 | -3.45 | 1.83 | 8.54 | 3.19 | Upgrade
|
Dividend Per Share | - | - | - | 0.250 | 0.250 | - | Upgrade
|
Gross Margin | 21.96% | 25.90% | 17.56% | 34.54% | 42.52% | 41.75% | Upgrade
|
Operating Margin | -9.12% | -8.00% | -13.21% | 3.46% | 15.54% | 9.32% | Upgrade
|
Profit Margin | -12.49% | -20.81% | -29.61% | -3.89% | 11.25% | 2.17% | Upgrade
|
Free Cash Flow Margin | - | 2.05% | -13.26% | 6.72% | 17.16% | 7.77% | Upgrade
|
EBITDA | -29 | 23.16 | -38.17 | 192.58 | 472.65 | 329.22 | Upgrade
|
EBITDA Margin | -2.30% | 2.22% | -2.93% | 14.04% | 23.36% | 19.68% | Upgrade
|
D&A For EBITDA | 86.13 | 106.73 | 134.19 | 145.11 | 158.24 | 173.39 | Upgrade
|
EBIT | -115.13 | -83.57 | -172.36 | 47.47 | 314.41 | 155.83 | Upgrade
|
EBIT Margin | -9.12% | -8.00% | -13.21% | 3.46% | 15.54% | 9.32% | Upgrade
|
Effective Tax Rate | - | - | - | - | 22.77% | 23.39% | Upgrade
|
Revenue as Reported | - | 1,044 | 1,314 | 1,374 | 2,024 | 1,675 | Upgrade
|
Advertising Expenses | - | 0.66 | 3.24 | 0.34 | 0.5 | 0.56 | Upgrade
|
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.